$2.09
+0.0100 (+0.481%)
At Close: Jul 31, 2026
Health Catalyst (HCAT) Gets a Buy Rating from Canaccord Genuity
10:06am, Monday, 13'th Apr 2020
In a report issued on April 9, Richard Close from Canaccord Genuity maintained a Buy rating on Health Catalyst (HCAT), with a price target of $40.00. The
Health Catalyst (HCAT) Gets a Buy Rating from Canaccord Genuity
10:05am, Monday, 13'th Apr 2020
In a report issued on April 9, Richard Close from Canaccord Genuity maintained a Buy rating on Health Catalyst (HCAT
Health Catalyst, Inc. Prices Upsized Offering of $200 Million 2.50% Convertible Senior Notes Due 2025
04:34am, Thursday, 09'th Apr 2020
Health Catalyst, Inc. (HCAT) (the “Company” or “Health Catalyst”) announced today the pricing of $200.0 million aggregate principal amount of 2.50% convertible senior notes due 2025 (the “n
Fly Intel: Pre-market Movers EHTH;NVAX;PINS;UPS;FDX;RPM;SGH;GNMK;TLGT;AMC;HCAT;GLUU;IQ;W
01:36pm, Wednesday, 08'th Apr 2020
Fly Intel: Pre-market Movers EHTH NVAX PINS UPS FDX RPM SGH GNMK TLGT AMC HCAT GLUU IQ W
Health Catalyst, Inc. Announces Proposed Offering of $175 Million Convertible Senior Notes
10:59am, Wednesday, 08'th Apr 2020
Health Catalyst, Inc. (HCAT) (the “Company” or “Health Catalyst”) announced today that it intends to offer, subject to market conditions and other factors, $175.0 million aggregate principal
Health Catalyst (NASDAQ:HCAT) Shares Purchased by Janus Henderson Group PLC
11:28am, Monday, 06'th Apr 2020
Janus Henderson Group PLC increased its position in shares of Health Catalyst (NASDAQ:HCAT) by 4.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Secu
Morgan Stanley likes Bristol-Myers Squibb in premarket analyst action
11:20am, Thursday, 02'nd Apr 2020
Exact Sciences (NASDAQ:EXAS) initiated with an Outperform rating and a $70 (25% upside) price target at Evercore ISI.Health Catalyst (NASDAQ:HCAT) initiated with a Buy rating and a $40 (47% upside) pr
Analysts Offer Insights on Technology Companies: Health Catalyst (HCAT) and Okta (OKTA)
10:16am, Thursday, 02'nd Apr 2020
Analysts have been eager to weigh in on the Technology sector with new ratings on Health Catalyst (HCAT) and Okta (OKTA). Health Catalyst (HCAT) Canaccord
Analysts Offer Insights on Technology Companies: Health Catalyst (NASDAQ: HCAT) and Okta (NASDAQ: OKTA)
10:16am, Thursday, 02'nd Apr 2020
Analysts have been eager to weigh in on the Technology sector with new ratings on Health Catalyst (
HCAT
–
Research Report
) and Okta (
OKTA
–
Research Report
).
Health Catalyst (HCAT)
Canaccord G
Health Catalyst Launches Four Additional COVID-19 Solutions and a Modular Bundle
12:37pm, Tuesday, 31'st Mar 2020
Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced meaningful developments in its in
SunTrust Robinson Reaffirms Their Buy Rating on Health Catalyst (HCAT)
05:42pm, Thursday, 26'th Mar 2020
In a report released today, Sandy Draper from SunTrust Robinson maintained a Buy rating on Health Catalyst (HCAT), with a price target of $35.00. The
SunTrust Robinson Reaffirms Their Buy Rating on Health Catalyst (HCAT)
05:42pm, Thursday, 26'th Mar 2020
In a report released today,
Sandy Draper
from SunTrust Robinson maintained a
Buy
rating on Health Catalyst (
HCAT
–
Research Report
), with a price target of
$35.00
. The company’s shares closed l
3 Healthcare Stocks to Buy for AI and Big Data
05:15pm, Thursday, 26'th Mar 2020
Healthcare stocks are in the spotlight as the coronavirus brings to light the importance of collecting data and using it to predict outcomes.
Sign In
Buy HCAT